To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open16.38
High16.38
Low16.38
Prev. Close15.6
Avg. Traded Price16.38
Volume52,377

MARKET DEPTH

info2
Total bid1,07,302.00
Total ask0.00
OrdersQtyBid
515575116.38
55034016
2315.99
1100015.75
615815.6
AskQtyOrders
000
000
000
000
000

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

16.386 hours ago
16.386 hours ago
arrow

LOWER/UPPER CIRCUITS

14.82
16.38
arrow
Ortin Global Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteAnnual Net Profit,rose 89.47% in the last year to ₹0.85 Cr. Its sector's average net profit growth for the last fiscal year was 38.71%.
noteQuarterly Net profit,rose 96.04% YoY to ₹0.16 Cr. Its sector's average net profit growth YoY for the quarter was 21.52%.
noteDebt to Equity Ratio,of 0.13 is less than 1 and healthy. This implies that its assets are financed mainly through equity.
View more

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : 4.33%
Net profit growth 5Y CAGR : %
Ortin Laboratories a Trusted Reliance for Quality to offer QUALITY Drugs and Medicines to the suffering mankind. The company’s Formulations unit is located in a spacious area with all ultra-modern infrastructures as per the WHO GMP Standards to manufacture the complete range of Pharmaceutical Formulations of TABLETS CAPSULES SYRUPS and DRY POWDERS. The company’s Drug API Intermediates manufacturing unit has been certified as an ISO 9001: 2008 company by Det Norske VERITAS The Netherlands for its quality systems management which shows the quality conscious to deliver best quality products. The company is marketing its formulations all over India and its products have been well accepted by the medical profession.
personal

Grow your wealth with more research recommendations

+91